CA2082806A1 - Immunoassays for anti-hiv-1 antibodies - Google Patents

Immunoassays for anti-hiv-1 antibodies

Info

Publication number
CA2082806A1
CA2082806A1 CA 2082806 CA2082806A CA2082806A1 CA 2082806 A1 CA2082806 A1 CA 2082806A1 CA 2082806 CA2082806 CA 2082806 CA 2082806 A CA2082806 A CA 2082806A CA 2082806 A1 CA2082806 A1 CA 2082806A1
Authority
CA
Canada
Prior art keywords
antigen
hiv
antibodies
kit
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2082806
Other languages
English (en)
French (fr)
Inventor
James R. Rusche
Albert T. Profy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Repligen Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2082806A1 publication Critical patent/CA2082806A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56988HIV or HTLV
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA 2082806 1990-06-08 1991-06-07 Immunoassays for anti-hiv-1 antibodies Abandoned CA2082806A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53576790A 1990-06-08 1990-06-08
US535,767 1990-06-08

Publications (1)

Publication Number Publication Date
CA2082806A1 true CA2082806A1 (en) 1991-12-09

Family

ID=24135683

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2082806 Abandoned CA2082806A1 (en) 1990-06-08 1991-06-07 Immunoassays for anti-hiv-1 antibodies

Country Status (4)

Country Link
EP (1) EP0532673A1 (enExample)
JP (1) JPH05507559A (enExample)
CA (1) CA2082806A1 (enExample)
WO (1) WO1991019011A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0554389T4 (da) * 1990-10-17 2002-11-11 Us Health Molekylære kloner af HIV-1 og anvendelse deraf
CA2874688C (en) * 2012-05-30 2021-06-29 Bio-Rad Innovations Method for diagnosing and differentiating hiv-2 infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659678A (en) * 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
US4725669A (en) * 1984-11-09 1988-02-16 President And Fellows Of Harvard College Assay for detecting infection by human T-cell lymphotropic virus-III
JPH04502760A (ja) * 1988-10-03 1992-05-21 レプリゲン・コーポレーション エイズの診断,予防および治療に有効な新規hiv蛋白質およびペプチド

Also Published As

Publication number Publication date
EP0532673A1 (en) 1993-03-24
EP0532673A4 (enExample) 1994-03-30
WO1991019011A1 (en) 1991-12-12
JPH05507559A (ja) 1993-10-28

Similar Documents

Publication Publication Date Title
Bettaieb et al. Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura
US4808536A (en) Immunochemical method for detection of antibody against HTLV-III core protein based upon recombinant HTLV-III gag gene encoded protein
NZ228302A (en) Peptides associated with htlv-1
US5587285A (en) Generation serological assay for monitoring HIV exposure
WO1992008983A1 (en) Hiv marker/aids vaccine
Dorn et al. Analysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type 1 (HIV-1) group M and its impact on HIV-1 antibody detection
US6458528B1 (en) Diagnosis of feline immunodeficiency virus infection using ENV/GAG polypeptide markers
JP2650217B2 (ja) Htlv―1感染の診断、治療及び予防接種のためのペプチド
WO1991013360A1 (en) NEW HIV p24 PEPTIDES, DIAGNOSTIC ANTIGENS AND DISCRIMINATIVE IMMUNOASSAY METHOD
CA2082806A1 (en) Immunoassays for anti-hiv-1 antibodies
JP3421336B2 (ja) 合成ペプチドを用いてのhtlv−▲i▼とhtlv−▲ii▼との区別
JP3889045B2 (ja) Hivを検出するためのペプチド
Norrby et al. Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein
CN111995666A (zh) 用于检测微生物的干扰肽和方法
US20100092940A1 (en) Method and Device for Detecting Feline Immunodeficiency Virus
US5134227A (en) DNA encoding immunoreactive, chimeric HTLV-III GAG proteins
AU2004304348B2 (en) Method and device for detecting feline immunodeficiency virus
Lombardi et al. Detection of antibodies to human immunodeficiency virus type I by using synthetic peptides and time-resolved fluoroimmunoassay (TR-FIA)
EP1013766B1 (en) Peptides for the detection of HIV-1-Group O
JPH02111791A (ja) Hiv抗体と免疫化学的に反応する合成ポリペプチド
US20050208067A1 (en) Method and device for detecting feline immunodeficiency virus
Bugge et al. Competition ELISA using a human monoclonal antibody for detection of antibodies against human immunodeficiency virus type 1
US20060002957A1 (en) Method and device for detecting feline immunodeficiency virus
JPH0215098A (ja) Hiv−1感染検出用合成ペプチド杭原、その組成物およびその使用方法
Müller et al. Rapid, easy and economical dot EIA for detection of antibodies to HIV-1 using recombinant env-and gag-proteins

Legal Events

Date Code Title Description
FZDE Dead